Chinese Clinical Oncology
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
- Oncology 231
- Pancreatic and Hepatic Oncology Research 54
- Cancer Immunotherapy and Biomarkers 42
- Colorectal Cancer Treatments and Studies 31
- Hepatology 61
- Hepatocellular Carcinoma Treatment and Prognosis 61
Chinese Clinical Oncology
779 papers receiving 7.3k citations
Peers
Comparison fields: 5 of 127
- Oncology 1.7k
- Otorhinolaryngology 364
- Cancer Research 720
- Hepatology 463
- Genetics 328
Countries where authors publish in Chinese Clinical Oncology
This map shows the geographic impact of research published in Chinese Clinical Oncology. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Chinese Clinical Oncology with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chinese Clinical Oncology more than expected).
Fields of papers published in Chinese Clinical Oncology
This network shows the impact of papers published in Chinese Clinical Oncology. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Chinese Clinical Oncology.
About Chinese Clinical Oncology
The 855 papers published in Chinese Clinical Oncology in the last decades have received a total of 7.5k indexed citations . Papers published in Chinese Clinical Oncology usually cover Oncology (231 papers), Hepatology (61 papers), Pulmonary and Respiratory Medicine (187 papers), Cancer Research (80 papers) and Genetics (42 papers) specifically the topics of Hepatocellular Carcinoma Treatment and Prognosis (61 papers), Breast Cancer Treatment Studies (55 papers), Pancreatic and Hepatic Oncology Research (54 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (44 papers), Cancer Immunotherapy and Biomarkers (42 papers), Glioma Diagnosis and Treatment (40 papers), Lung Cancer Treatments and Mutations (39 papers) and Colorectal Cancer Treatments and Studies (31 papers). The most active scholars publishing in Chinese Clinical Oncology are Yun Shin Chun, Geoffrey Yuyat Ku, Lewis Rowland Roberts, Lorena Marcano-Bonilla, Tomoharu Sugie, Ghassan K. Abou-Alfa, Kah-Whye Peng, Luke Russell, Peter J. Allen and Vishal Jindal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.